14 December 2016, Brussels, Belgium
Large-Scale Research, Development and Innovation (RDI) Initiatives also known as LSIs are increasingly playing a vital role across Europe for the development and commercialisation of new novel products and services.
The EU-GREAT! project is exploring the best practices and barriers faced by stakeholders of LSIs in combining funds from different public and private sources.
This Workshop aims at disseminating the main lessons learnt during the project implementation as well as key recommendations for improving the administrative and policy frameworks of public-private funding instruments to ease the combination of funding and stimulate investments.
14 December 2016, Brussels
Large-Scale Research, Development and Innovation (RDI) Initiatives (LSIs) are playing a vital role across Europe for the development and commercialisation of novel products and services. The EU-GREAT! project is exploring the best practices and identifying barriers faced by stakeholders of LSIs in combining funds from different public and private sources.
This Workshop aims at disseminating the main lessons learnt and key recommendations for improving the administrative and policy frameworks of public-private funding instruments to ease the combination of funding and stimulate investments.
9-14 January 2017, Hinxton, United Kingdom
The programme will focus on several disorders including Alzheimer’s disease, Parkinson’s disease, Fragile X, Spinocerebellar ataxia and amyotrophic lateral sclerosis.
12-13 January 2017, Leuven, Belgium
Our progressive understanding of mechanisms involved in acute and chronic liver diseases has led to important improvements in the current management of these diseases.
Basic research in the field of liver- development, cancer, viral infections, fibrosis, and regeneration is important to warrant further insight into the molecular and cellular processes implicated in order to develop novel detection methods and therapies.
This meeting will bring together international scientists working in the field of liver disease. The meeting will provide a unique opportunity to get updated on and discuss new studies in the field of basic liver research.
Topics will include:
24 January 2017, Brno, Czech Republic
The purpose of these regional workshops is to fully inform ‘newcomers’ (research-performing institutions and research funders) on the principles of Charter and Code and their implementation in the research institution via a step-wise procedure called the Human Resources Strategy for Researchers (HRS4R).
Registration is now open for the event in Brno.
The workshop in Brno is restricted to participants from Slovakia and the Czech Republic.
1-2 December 2016, Amsterdam, Netherlands
The ability of gut microbiota to communicate with the brain is emerging as an exciting concept in health and disease. Mounting evidence, mostly from rodent studies, suggests that gut microbes help shape normal neural development, brain biochemistry, and behaviour.
Bridging the gap between animal studies and application for treatment in humans will be the next big challenge. There are still many mysteries when it comes to understanding how the microbiome might affect the brain.
If research is able to solve even a fraction of them, the microbiota-brain axis could be a powerful target for influencing mood and behaviour, for example in anxiety and depression, as well as preventing or treating brain-related diseases, including (potentially) Parkinson’s disease, Alzheimer’s disease, schizophrenia and autism.
MIND, MOOD & MICROBES – the 1st International Conference on Microbiota-Gut-Brain Axis – is focused on breakthroughs in fundamental research and dissemination of fundamental research towards clinical applications.
The conference is designed for academia, health professionals and health-related industries.
30 November - 1 December 2016, Berlin, Germany
It is our pleasure to invite you to participate in The World Congress on Clinical Trials in Diabetes (WCTD2016), which will take place 30 November - 1 December 2016, in Berlin, Germany.
With the multitude of complex issues associated with clinical trials in diabetes, it is clear that there is a necessity to streamline these issues into a process that will improve drug development in terms of approval and commercialization and address the various aspects of drug and device development and the way to enhance them.
1 December 2016, Brussels, Belgium
Since its launch in 2010, the EU's Factories of the Future partnership has been responsible for the launch of 248 pre-competitive projects which are transforming manufacturing.
The event is focused on the successful industrial exploitation of results from these projects. This event will include ‘Pitch’ sessions which will focus on providing short and to-the-point presentations (‘pitches’) about innovative manufacturing technologies and approaches by projects.
Factories of the Future - Making Innovation Happen is also an excellent opportunity for interested organisations to connect with some of Europe’s leading industrial companies and research organisations.
28 November - 1 December 2016, Amsterdam, Netherlands
Connecting Cell and Gene Therapy Leaders to drive manufacturing and commercialisation through direct access to innovative discovery, product development and regulatory know-how.
30 November - 1 December 2016, Brussels
GREAT START IN LIFE! The best possible education in early years
Brussels, 30 November – 1 December 2016, Hotel Husa President Park, Boulevard du Roi Albert II, 44
Who? Researchers, policy makers, early childhood education and care and primary school staff.
What? Create the conditions for the best possible education in the early years (ages 0-12), combat inequalities, include vulnerable groups
Information and registration https://great-start-in-life.teamwork.fr/en password: GSIL2016
Co-organized by: DG Research and Innovation, Unit B6 (Open and Inclusive Societies) and DG Education and Culture, Unit B2 (Schools and Educators; Multilingualism)